Accexible Speech Analysis for MCI Detection and Monitoring in Colombia
NCT: NCT07553117 · COMPLETED
Brief Summary
Mild Cognitive Impairment (MCI) is frequently underdiagnosed due to its subtle clinical presentation. This study evaluates the diagnostic performance of AcceXible, a speech analysis-based machine learning platform, compared to the Montreal Cognitive Assessment (MoCA) for MCI detection and monitoring in Colombian patients. A diagnostic test accuracy study will be conducted within a primary care setting (EPS Sanitas), including prior validation of the AcceXible protocol in the Colombian healthcare context. The study pursues two primary aims: (1) to validate the AcceXible tool in a Colombian population, and (2) to demonstrate that AcceXible achieves high diagnostic accuracy for early MCI detection and longitudinal monitoring relative to the MoCA.
Frequently Asked Questions
What is Accexible Speech Analysis for MCI Detection and Monitoring in Colombia?
Accexible Speech Analysis for MCI Detection and Monitoring in Colombia is a clinical trial registered under NCT07553117. Current status: COMPLETED.
What is the status of NCT07553117?
The current status of NCT07553117 (Accexible Speech Analysis for MCI Detection and Monitoring in Colombia) is: COMPLETED.
When did Accexible Speech Analysis for MCI Detection and Monitoring in Colombia start?
Accexible Speech Analysis for MCI Detection and Monitoring in Colombia started on 2022-05-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.